Long-term Relapse of Type 2 Diabetes After Roux-en-Y Gastric Bypass: Prediction and Clinical Relevance.
Jean DebédatNataliya SokolovskaMuriel CoupayeSimona PanunziRima ChakarounLaurent GenserGarance de TurenneJean-Luc BouillotChristine PoitouJean-Michel OppertMatthias BlüherMichael StumvollGeltrude MingroneSéverine LedouxJean-Daniel ZuckerKarine ClémentJudith Aron-WisnewskyPublished in: Diabetes care (2018)
The 5y-Ad-DiaRem accurately predicts 5y-DR and appears relevant to identify patients at risk for relapse. Using this score could help personalize patient care after the 1st year post-RYGB to maximize weight loss, limit weight regains, and prevent relapse.
Keyphrases
- roux en y gastric bypass
- weight loss
- gastric bypass
- bariatric surgery
- type diabetes
- end stage renal disease
- obese patients
- glycemic control
- free survival
- chronic kidney disease
- newly diagnosed
- ejection fraction
- weight gain
- prognostic factors
- body mass index
- peritoneal dialysis
- insulin resistance
- editorial comment
- patient reported